Crossmark

Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports

Crossref DOI link: https://doi.org/10.1186/s40425-019-0598-9

Published Online: 2019-05-02

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Noseda, Roberta http://orcid.org/0000-0002-4946-7926
Bertoli, Raffaela

Müller, Laura

Ceschi, Alessandro
License Information

Text and Data Mining valid from 2019-05-02
More Information

Article History

Received: 13 December 2018

Accepted: 22 April 2019

First Online: 2 May 2019

Ethics approval and consent to participate

: Ethical approval was not required according to the Swiss Human Research Act (no intervention with human subjects or access to identifiable information).

: Not applicable.

: The authors declare that they have no competing interests.Study results and conclusions are those of the authors and do not necessarily represent the opinion of the WHO.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below